Trial · NCT02764385
Using a Teachable Moment Communication Process to Improve Outcomes of Quitline Referrals
NCT02764385, Not applicable, Completed, Case Western Reserve University; results first posted 2021-07-27
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Using a Teachable Moment Communication Process to Improve Outcomes of Quitline Referrals. Trials, record NCT02764385. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02764385
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Using a Teachable Moment Communication Process to Improve Outcomes of Quitline Referrals
- NCT number
- NCT02764385
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 15,786 participants, actual
- Lead sponsor
- Case Western Reserve University
- Conditions
- Smoking, Tobacco Dependence
- Interventions
- Teachable Moment Communication Process, AAC
- First posted
- 2016-05-06
- Last updated
- 2021-07-27
- Results first posted
- 2021-07-27
- Limitations and caveats
Intent to treat analyses are presented. Of the 60 eligible clinicians, 44 had exposure to the Teachable Moment Communication Process training. Uptake and use of the communication process during patient visits was limited (less than 10% of eligible visits). This makes it difficult to evaluate the added value of the Teachable Moment Communication Process intervention over and above the Ask-Advise-Connect approach.
Source ClinicalTrials.gov
Registered outcomes2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of Patients Contacted for Quitline Enrollment | Every visit until end of study, up to 6 months post TMCP implementation | The number of patients contacted by the Quitline among those ready to quit and who accepted a referral to the quitline |
| Secondary | Number of Patients With Documentation of Brief Advice | Every visit until end of study, up to 6 months post TMCP implementation | The number of patients that use tobacco with documentation of brief advice |
Source ClinicalTrials.gov
Outcomes2
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Number of Patients Contacted for Quitline Enrollment | Every visit until end of study, up to 6 months post TMCP implementation | unit is the patient; among referrals received by the quitline, documented as contacted. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Patients With Documentation of Brief Advice | Every visit until end of study, up to 6 months post TMCP implementation | number of smokers | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.gov
Results by group4
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Patients Contacted for Quitline Enrollment | AAC Only | 273 | Participants | ||
| Number of Patients Contacted for Quitline Enrollment | AAC + TMCP | 59 | Participants | ||
| Number of Patients With Documentation of Brief Advice | AAC Only | 7086 | Participants | ||
| Number of Patients With Documentation of Brief Advice | AAC + TMCP | 5579 | Participants |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | AAC Only | 9,145 | |
| Overall Study | STARTED | AAC + TMCP | 6,641 | |
| Overall Study | COMPLETED | AAC Only | 9,145 | |
| Overall Study | COMPLETED | AAC + TMCP | 6,641 | |
| Overall Study | NOT COMPLETED | AAC Only | 0 | |
| Overall Study | NOT COMPLETED | AAC + TMCP | 0 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | AAC Only | 0 | 0 |
| Total, all-cause mortality | AAC + TMCP | 0 | 0 |
| Total, other adverse events | AAC Only | 0 | 0 |
| Total, other adverse events | AAC + TMCP | 0 | 0 |
| Total, serious adverse events | AAC Only | 0 | 0 |
| Total, serious adverse events | AAC + TMCP | 0 | 0 |
Source ClinicalTrials.gov
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 33947346 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons2
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| AAC Only vs AAC + TMCP: Number of Patients With Documentation of Brief Advice | Trial comparisons |
| AAC Only vs AAC + TMCP: Number of Patients Contacted for Quitline Enrollment | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02764385
GET https://conductscience.org/api/trials/v1/NCT02764385/registered